Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Zomedica Pharmaceuticals' diagnostics development work is set to benefit from funding awarded to one of its R&D partners.
In 2018, the stand-out M&A deals targeted diagnostics, digital technologies and nutrition. While Zoetis and Merck Animal Health made multi-billion-dollar deals, some of the sector's smaller purchases also hinted towards important trends. Animal Pharm editor Joseph Harvey looks back at where the money was spent.
During 2018, there were a whole host of developments in the veterinary diagnostics market. Although this sector is relatively young and has a small number of dedicated players, it is receiving a lot of attention from animal health companies big and small. Animal Pharm editor Joseph Harvey investigates.
Zomedica Pharmaceuticals plans to begin marketing three of its diagnostics in the US over the course of 2020.
German firm AniCon Labor is increasing its sales base for its veterinary diagnostic products and autogenous vaccines outside its domestic market.
Melanie Winowiecki has joined the board of directors of Xip Diagnostics – a developer of analytical point-of-care tests for both human and animal health.
Heska has purchased certain Cuattro digital imaging software and related assets.
US firm Zomedica Pharmaceuticals has brought new point-of-care (POC) diagnostic technology into its portfolio, following an exclusive deal with Qorvo Biotechnologies.
A new collaborative report from Animal Pharm and Stonehaven Consulting has highlighted the leading start-up companies in the animal health space.
Heska has become the sole provider of point-of-care diagnostics and consumables to Ethos Veterinary Health.
Singapore-based Credo Biomedical is seeking global partners to take its point-of-care (POC) molecular diagnostics for companion animals to a wider sales base.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.